Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • January 20, 2024

Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Jan 19. doi: 10.1007/s12325-023-02773-x. Epub ahead of print. PMID: 38240949.

Tags: Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT2I

Comparing Cardiovascular Events Across Home Dialysis Modalities: Adjusting the Unadjustable?

Nadeau-Fredette AC, Shen JI, Perl J. Comparing Cardiovascular Events Across Home Dialysis Modalities: Adjusting the Unadjustable? Kidney360. 2024 Apr 1;5(4):489-491. doi: 10.34067/KID.0000000000000397. PMID: 38662536.

Artificial intelligence in medicine and nephrology: hope, hype, and reality

Glassock RJ. Artificial intelligence in medicine and nephrology: hope, hype, and reality. Clin Kidney J. 2024 Mar 22;17(4):sfae074. doi: 10.1093/ckj/sfae074. PMID: 38618490; PMCID: PMC11015150.

Prognostic Scoring in IgA Vasculitis

Glassock RJ. Prognostic Scoring in IgA Vasculitis. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):409-411. doi: 10.2215/CJN.0000000000000444. PMID: 38598194.